EDA概念股拉昇 概倫電子漲近13% 南京EDA創新中心已向科技部申報
格隆匯8月18日丨EDA概念股盤中出現一波快速拉昇走勢,截至半日收盤,概倫電子漲近13%,東土科技漲近10%,華大九天漲近6%,廣立微漲近5%,安路科技漲近4%。2022世界半導體大會8月18日-20日在南京國際博覽中心舉辦,共同探討全球半導體產業發展大勢。江蘇省工業和信息化廳副廳長池宇在會上稱,目前,南京EDA創新中心已經報到科技部,正在審批當中,是國內第一個報到科技部的EDA創新中心。另外,此前有消息稱,美國商務部祭出新禁令,禁止對中國出口3納米以下的EDA(電子設計自動化)工具,中國EDA或迎國產替代機遇。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.